Allergan

SEC hands Allergan a $15M speeding ticket for blowing off disclosure rules in a tough 2014 fight against Valeant
Endpoints
Tue, 01/17/17 - 10:12 pm
SEC
Allergan
Valeant Pharmaceuticals
M&A
Actavis
Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
TheStreet.com
Wed, 01/11/17 - 10:04 am
Allergan
Brent Saunders
Pharma CEOs
M&A
JPMHC 2017
Allergan CEO on the Hot Seat: Here's What He Had to Say
Motley Fool
Sat, 01/7/17 - 12:36 pm
Allergan
Pharma CEOs
Brent Saunders
FDA accepts Allergan’s new drug application for Liletta contraception device
Mass Device
Wed, 01/4/17 - 10:47 am
FDA
Allergan
Liletta
contraceptives
devices
What Was Wrong For Allergan In 2016 And Why 2017 Is Likely To Be Different
Seeking Alpha
Tue, 12/27/16 - 10:12 am
Allergan
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Ophthalmic Drugs Market
Ocular Therapeutix
Eylea
Restasis
Lucentis
Regeneron
Roche
Allergan
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
Seeking Alpha
Wed, 12/21/16 - 10:53 am
Allergan
dry eye disease
Restasis
Shire
Xiidra
Allergan picks up regenerative med company for $2.9B
BioPharma Dive
Wed, 12/21/16 - 10:47 am
Allergan
M&A
regenerative medicine
Acelity
devices
Allergan eyes depression as blockbuster Botox's next big stage
Fierce Pharma
Mon, 12/19/16 - 11:44 am
Allergan
Botox
clinical depression
Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
Motley Fool
Sat, 12/17/16 - 12:23 pm
biotech
Allergan
Gilead Sciences
Genfit
Intercept Pharmaceuticals
NASH
Allergan subsidiary settles kickback charges for $38M
BioPharma Dive
Sat, 12/17/16 - 12:12 pm
Allergan
Forest Labs
kickbacks
False Claims Act
whistleblower lawsuits
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
Mylan scores review of Allergan's Restasis IP, but analysts aren't worried about the med's fate
Fierce Pharma
Sun, 12/11/16 - 11:44 am
Mylan Labs
Allergan
Restasis
patents
generics
Is the US biopharma industry headed for a turning point in 2017?
Endpoints
Tue, 12/6/16 - 10:43 pm
drug pricing
Allergan
Novo Nordisk
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Amgen
Allergan
Avastin
biosimilars
Europe
ABP 215
non-squamous lung cancer
Pharma execs assess landscape under President Trump
Drug Delivery Business
Sat, 12/3/16 - 09:22 am
Donald Trump
pharma industry
drug pricing
Regeneron
Allergan
Analyzing Allergan’s Growth Pharma Plans
Market Realist
Tue, 11/29/16 - 05:34 pm
Allergan
Ex-Allergan prez Ingram forges $1B deal to sell Alzheimer’s biotech to Brent Saunders and the new crew at Allergan
Endpoints
Tue, 11/22/16 - 09:55 pm
Allergan
Brent Saunders
Doug Ingram
Alzheimer's disease
Chase Pharmaceuticals
FDA clears Allergan’s Xen gel stent for glaucoma
Mass Device
Tue, 11/22/16 - 12:01 pm
FDA
Allergan
Xen gel stent
glaucoma
devices
eye health
3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3
Motley Fool
Fri, 11/18/16 - 10:08 am
Teva Pharmaceutical
Allergan
JNJ

Pages